In a phase 2 clinical trial conducted on an obese population, over a 26-week period, patients who were administered a dose range of efinopegdutide from 5 mg to 10 mg experienced a weight reduction of up to 11.8%
Embarking on a weight loss journey is a significant decision
l , SMART1 promoted ubiquitination of Smurf1 (SMART1: 0.2 M, 1 M, 5 M, SMART1-L: 1 M or Poma: 1 M)
Yet, its this sort of, I think, massive kind of new approach based on better understanding of mechanisms underlying severe psychiatric illness
In the context of shared mechanistic pathways relevant to thyroidbrain interactions, these data remain biologically informative, yet they also highlight a critical gap in thyroid-specific primary research
Davis, D